Alcon has launched the new Clareon AutonoMe IOL and delivery system across Australia and New Zealand at its Synergeyes Clinical Symposium in Sydney.
According to the company, the Clareon AutonoMe builds on the success of the AcrySof Platform, with over 100 million implants worldwide.1,2
AutonoMe is the “first and only automated, disposable, preloaded IOL delivery system enabling easy, intuitive controlled IOL delivery”.5 The Clareon IOL hydrophobic acrylic IOL is made of a patented, innovative optic polymer material with an advanced design, that “enables sharp, crisp vision; low edge glare; and unsurpassed optic clarity”.3-7
“With the introduction of Clareon AutonoMe, we are proud to commercially launch our latest innovations to benefit Australian and New Zealand surgeons and their cataract patients” said Karen Fowler, Country Business Head, Surgical Australia and New Zealand. “We have received great feedback from our local surgeons who have had early access to the technologies. Clareon AutonoMe builds on the comprehensive legacy of AcrySof by offering surgeons easy, intuitive control of IOL delivery with the newest optic material.”
Clareon AutonoMe builds on the comprehensive legacy of AcrySof
According to Alcon, the AutonoMe delivery system, preloaded with the Clareon IOL, is designed with advancements intended to benefit both surgeons and cataract patients. Its automated CO2 powered delivery mechanism and intuitive, ergonomic design allows precise and simplified single handed control of IOL placement during cataract surgery.4,8 The Clareon hydrophobic acrylic IOL is made of a patented, innovative optic polymer material. Clareon builds on and maintains the benefits of the proven AcrySof platform with a new optic BioMaterial that offers cataract patients’ unsurpassed clarity.8-13
References
Go to mivisionclean2.flywheelsites.com
